Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Events
Jun 10, 2024 at 2:40 PM EDT
May 14, 2024 at 3:00 PM PDT
May 13, 2024 at 11:30 AM EDT
SEC Filings
Filing date | Description | Form |
---|---|---|
D | ||
D | ||
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS |